Skip to Content
Director of Finance-BioPharma

Company Size & Timeframe

  • $1+ billion in revenue
  • 2 months
  • Results

    • Top management gained full visibility
    • Flexible reporting model to help ensure attainment of EBITDA goals
  • Company Profile & Position

    • Publicly traded company
    • Interim Director of Finance
  • Situation

    • Company had aggressive goals for increasing revenue
    • Ambitious plans for developing numerous new products
    • Skyrocketing development costs affected EBITDA, but no visibility to full impact
  • Implementation

    • Developed a complex matrix and control program to forecast and track expenses
    • Created detailed forecast P&L and YTD actual per project
    • Redesigned reporting process to facilitate population of forecast and actual figures
    • Trained staff for ongoing reporting accuracy

Cerius Insights

The interim completed the P&L project, providing critical information to senior management necessary to plan and execute a cost restructuring. Also, we had positive realignment among the functional departments as a result of the new information the interim provided.”

Back to top